Inglês

Sample ID, analyte type, body site where sample was obtained, sequencing center, tumor specimen, and tumor status of sample of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.

9 Formulários  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, affection status, consent group, subject source, and source subject ID of participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    3. Subject ID, sample ID, sample source, source sample ID, study accession ID, and sample use variable obtained from participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    4. Subject ID, age, gender of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    5. Sample ID, analyte type, body site, and histological type of tumors of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    6. Subject ID, age, gender, and race of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    7. Sample ID, analyte type, body site where sample was obtained, sequencing center, tumor specimen, and tumor status of sample of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    8. Subject ID, gender, diagnosis age, race, and study stage of participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
    9. Sample ID, analyte type, body site where sample was obtained, sequences center, and tumor status of sample obtained from participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
pht004476
Descrição

pht004476

Alias
UMLS CUI [1,1]
C3846158
Body site where sample was collected
Descrição

BODY_SITE

Tipo de dados

string

Alias
UMLS CUI [1,1]
C0449705
Analyte type
Descrição

ANALYTE_TYPE

Tipo de dados

string

Alias
UMLS CUI [1,1]
C4744818
Tumor specimen extraction stage
Descrição

TUMOR_SPECIMEN

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0185115
UMLS CUI [1,3]
C0699749
Tumor status
Descrição

IS_TUMOR

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0475752
Name of the center which conducted sequencing
Descrição

SEQUENCING_CENTER

Tipo de dados

string

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0565990
UMLS CUI [1,3]
C1561491
De-identified sample ID
Descrição

SAMPLE_ID

Tipo de dados

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C1299222
Voltar ao início da página

Similar models

Sample ID, analyte type, body site where sample was obtained, sequencing center, tumor specimen, and tumor status of sample of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.

9 Formulários
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, affection status, consent group, subject source, and source subject ID of participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    3. Subject ID, sample ID, sample source, source sample ID, study accession ID, and sample use variable obtained from participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    4. Subject ID, age, gender of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    5. Sample ID, analyte type, body site, and histological type of tumors of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    6. Subject ID, age, gender, and race of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    7. Sample ID, analyte type, body site where sample was obtained, sequencing center, tumor specimen, and tumor status of sample of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    8. Subject ID, gender, diagnosis age, race, and study stage of participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
    9. Sample ID, analyte type, body site where sample was obtained, sequences center, and tumor status of sample obtained from participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
pht004476
C3846158 (UMLS CUI [1,1])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
Item
Tumor specimen extraction stage
text
C0475358 (UMLS CUI [1,1])
C0185115 (UMLS CUI [1,2])
C0699749 (UMLS CUI [1,3])
TUMOR_SPECIMEN
Code List
Tumor specimen extraction stage
CL Item
tumor specimens were obtained after chemotherapy (post chemotherapy)
CL Item
tumor specimens were obtained after radiation therapy (post radiation)
CL Item
tumor specimens were obtained before any treatment (primary resection)
Item
Tumor status
text
C0475752 (UMLS CUI [1,1])
IS_TUMOR
Code List
Tumor status
CL Item
Is not a tumor (N)
C0027651 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
CL Item
Is Tumor (Y)
C0027651 (UMLS CUI [1,1])
SEQUENCING_CENTER
Item
Name of the center which conducted sequencing
string
C1301943 (UMLS CUI [1,1])
C0565990 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
SAMPLE_ID
Item
De-identified sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
Voltar ao início da página